Published in Pneumonol Pol on January 01, 1976
Telomerase activity in transthoracic fine needle biopsy aspirates as a marker of peripheral lung cancer. Thorax (2007) 1.38
Influence of age and gender on serum eotaxin concentration in healthy and allergic people. J Investig Allergol Clin Immunol (2005) 0.94
Prevalence and risk factors for asthma in Poland: results from the PMSEAD study. J Investig Allergol Clin Immunol (2007) 0.92
Stimulatory effect of LH, PGE2 and progesterone on StAR protein, cytochrome P450 cholesterol side chain cleavage and 3beta hydroxysteroid dehydrogenase gene expression in bovine luteal cells. Prostaglandins Other Lipid Mediat (2005) 0.87
Apoptosis-, proliferation, immune function-, and drug resistance- related genes in ER positive, HER2 positive and triple negative breast cancer. Neoplasma (2012) 0.77
Eotaxin in serum of patients with asthma or chronic obstructive pulmonary disease: relationship with eosinophil cationic protein and lung function. Mediators Inflamm (2000) 0.77
[Oxygen uptake by granulocytes and lymphocytes of guinea pigs following specific and non-specific stimulation]. Acta Haematol Pol (1973) 0.75
[Three month treatment with budesonide in patients with corticoid dependent bronchial asthma--personal experience]. Pol Tyg Lek (1991) 0.75
[Radioimmunologic tests in specific immunotherapy of atopic rhinitis]. Wiad Lek (1984) 0.75
[Specific IgE antibodies in the sera of patients with allergic rhinitis]. Otolaryngol Pol (1986) 0.75
[Comparative studies of the effects of nifedipine, verapamil and diltiazem on respiratory mechanics in patients with atopic and non-atopic asthma]. Pol Tyg Lek (1989) 0.75
[Comparative evaluation of diagnostic skin tests and blastic lymphocyte transformation in patients with asthma]. Pol Tyg Lek (1974) 0.75
[Histamine changes in asthmatic conditions]. Pol Tyg Lek (1973) 0.75
[Role of adrenergic receptors in the mechanism of bronchial spasm]. Wiad Lek (1974) 0.75
[Effect of Zaditen on the clinical status and ventilatory parameters in patients with various types of bronchial asthma]. Pneumonol Pol (1985) 0.75
[Serum ACTH and cortisol levels in bronchial asthma during treatment with Kenalog]. Pneumonol Pol (1982) 0.75
[Changes in various immunobiochemical parameters in patients with bronchial asthma during specific desensitization]. Pneumonol Pol (1984) 0.75
[Blastic transformation of peripheral blood lymphocytes in patients with asthma]. Pol Tyg Lek (1974) 0.75
[Injection of a depot glucocorticoid in asthmatic patients. Changes in the biochemical parameters and clinical symptoms]. MMW Munch Med Wochenschr (1982) 0.75
[Evaluating the usefulness of tests from the 3M Diagnostics Systems and Biowhittaker firms in diagnosis of Lyme disease and Borreliosis]. Pneumonol Alergol Pol (1994) 0.75
[Diagnostic significance of alpha-2 macroglobulins in internal diseases. I. Asthma]. Pol Arch Med Wewn (1978) 0.75
[Attempted evaluation of the effect of tonsillectomy on the condition of the myocardium]. Wiad Lek (1969) 0.75
[Allergology in internet]. Pol Merkur Lekarski (2000) 0.75
[Squamous cell carcinoma antigen (Scc-Ag): diagnostic utility in squamous cell carcinoma antigen of the head and neck with metastasis to lymph nodes]. Otolaryngol Pol (2000) 0.75
[Calcium channel blockers and their value in the treatment of bronchial asthma]. Pneumonol Pol (1988) 0.75
[Blood histamine in some skin diseases]. Przegl Dermatol (1974) 0.75
[Comparative evaluation of the usefulness of various methods for studying the serum IgE levels in the diagnosis of atopic bronchial asthma]. Pol Tyg Lek (1987) 0.75
The comparative evaluation of alpha-2-macroglobulin and immunoglobulin levels in sera of patients with bronchial asthma. Allerg Immunol (Leipz) (1983) 0.75
[Role of arachidonic acid (ETE) and its metabolites in the pathogenesis of bronchial spasm. I. Metabolites formed under the effect of cyclooxygenase]. Pneumonol Pol (1983) 0.75
[Comparison of the clinical effects to the kinetics of prostaglandin (PGF2 alpha), cAMP, cortisol and ACTH behavior in the plasma of bronchial asthma patients treated with triamcinolone acetonide]. Pol Arch Med Wewn (1982) 0.75
[Perennial specific immunotherapy in pollen allergy]. Otolaryngol Pol (1997) 0.75
Interaction of lysosomal enzymes and their natural inhibitors in bronchoalveolar lavage fluid and serum in atopic bronchial asthma. Arch Immunol Ther Exp (Warsz) (1987) 0.75
[Serum lipids in patients with bronchial asthma]. Pol Tyg Lek (1989) 0.75
[Incidence of antigen expression for HLA antigens A,B,C and DR in patients with atopic diseases in Poland]. Pol Tyg Lek (1991) 0.75
[The role of aeroallergens monitoring in the allergological practice]. Otolaryngol Pol (1997) 0.75
[Exudative pleurisy in viral infection. Preliminary evaluation of diagnostic possibilities]. Pneumonol Pol (1986) 0.75
[Intal in the treatment of atopic extrinsic bronchial asthma. I. Effect on the ventilatory function]. Gruzlica (1974) 0.75
[The value of gastrointestinal antigens in the monitoring of patients with malignant head neoplasms]. Pol Merkur Lekarski (1998) 0.75
[Diagnosis of specific hypersensitivity to exogenous allergens by the raidallergosorbent test (RAST). I. Method and study of specificity of standard allergens in the Phadebas RAST kit]. Pol Arch Med Wewn (1979) 0.75
[Serum levels of specific and nonspecific IgE in blood donors]. Pol Tyg Lek (1988) 0.75
[Use of "rinoflow" inhalation in treatment of paranasal sinusitis]. Pol Merkur Lekarski (1997) 0.75
[Theophylline in the serum and bronchoalveolar lavage fluid (BALF) in patients with bronchospastic conditions]. Pneumonol Pol (1988) 0.75
[Usefulness of the dynamic spirometric indices in the assessment of the provocation test in some types of bronchial asthma]. Gruzlica (1975) 0.75
[Bronchodilating effect of Berodual in smokers and non-smokers with chronic bronchitis]. Pneumonol Pol (1988) 0.75
[Protracted steroid therapy in asthma. I. Immunoglobulins in atopic asthma]. Pneumonol Pol (1980) 0.75
[T lymphocyte subpopulations OKT-4 and OKT-8 in patients with bronchial asthma]. Pol Tyg Lek (1987) 0.75
[Usefulness of the Bronchoscreen apparatus in diagnosing bronchial hyperreactivity by the histamine provocation test]. Pol Tyg Lek (1989) 0.75
[Serum levels of tissue polypeptide antigen in patients with the head and neck cancer according to presence of metastases in lymph nodes]. Otolaryngol Pol (2000) 0.75
[Usefulness of pulmonary scintigraphy in the diagnosis of pulmonary embolism]. Pneumonol Pol (1988) 0.75
[Surgical treatment of rhinophyma using CO2 laser]. Otolaryngol Pol (1999) 0.75
[Effect of Zaditen on plasma immunoglobulin levels in patients with bronchial asthma]. Pneumonol Pol (1985) 0.75
[Squamous cell carcinoma antigen for monitoring patients with head neoplasm]. Pol Merkur Lekarski (1999) 0.75
[Diagnostic value of radioimmunological studies (RIA) as tests differentiating and defining bronchial asthma]. Pneumonol Pol (1980) 0.75
[Diagnosis of specific hypersensitivity to exogenous allergens by the radioallergosorbent test (RAST). II. Inhalatory allergens as risk factors in the development of asthma]. Pol Arch Med Wewn (1979) 0.75
[Preliminary studies of using plasmapheresis in the treatment of status asthmaticus in atopic bronchial asthma]. Pol Tyg Lek (1987) 0.75
[Laser surgery and interferon in the treatment of laryngeal papilloma]. Otolaryngol Pol (1997) 0.75
[Pleomorphic adenoma of the parapharyngeal space: a case report]. Otolaryngol Pol (1998) 0.75
[Lymph nodes metastases as a first sign of cancer]. Otolaryngol Pol (2000) 0.75
[Concentration of PGE and 13,14-dihydro-15-keto-PGF2 alpha in bronchial asthma during corticotherapy]. Pneumonol Pol (1980) 0.75
[Sarcoidosis of the paranasal sinuses]. Otolaryngol Pol (1998) 0.75
[Comparison of the effects of Kenalog and Zaditen on the clinical state and plasma cAMP levels of patients with bronchial asthma]. Pneumonol Pol (1985) 0.75
[Blood and plasma histamine in some allergic skin diseases and following administration of anti-inflammatory and anti-allergic drugs blocking autonomic ganglia after cigarette smoking]. Pol Tyg Lek (1972) 0.75
[Transient bronchial hyperreactivity in influenza]. Pol Tyg Lek (1989) 0.75
The depot-form of glucocorticoid decreases cortisol but not ACTH and beta-endorphin levels in human plasma. Horm Metab Res (1983) 0.75
[Use of long-acting drainage (sino-ject) in treatment of chronic maxillary sinusitis]. Pol Merkur Lekarski (1997) 0.75
[IgE level in patients with asthma]. Pol Arch Med Wewn (1976) 0.75
[Effect of Atrovent (ipratropium bromide) on the mechanics of respiration in patients with chronic obstructive pulmonary disease]. Pneumonol Pol (1986) 0.75
[Intal in the treatment of atopic extrinsic bronchial asthma. II. Effect of intal on histamine concentration and blastic index in peripheral blood]. Gruzlica (1974) 0.75
[Evaluation of the protective effects of nifedipine and verapamil in patients with bronchial hyperreactivity]. Wiad Lek (1989) 0.75
[Usefulness of immunological in vitro tests in the diagnosis of asthma with particular reference to radioimmunoassay]. Pol Tyg Lek (1977) 0.75
[Long-term therapy using beclomethasone preparations in our experience]. Pneumonol Pol (1988) 0.75
[Gastrointestinal cancer antigen and immunoglobulins G, A, M in patients with head cancer]. Otolaryngol Pol (1998) 0.75
[Clinical evaluation of triamcinolone and paramethasone in the treatment of chronic asthma]. Pneumonol Pol (1976) 0.75
[Endoscopic surgery of the sinus: own experiences]. Otolaryngol Pol (1997) 0.75
[The serum theophylline level in patients with chronic bronchitis treated with Theodur]. Pneumonol Pol (1988) 0.75
[Study of the effects of calcium antagonists on respiration mechanics in patients with occlusive ventilation impairment]. Wiad Lek (1989) 0.75
[Basic immunoglobulin level in asthma treated with delayed-action corticosteroids]. Pneumonol Pol (1980) 0.75
[Diagnostic value of osteotropic bone scintigraphy in maxillary sinus diseases]. Pol Merkur Lekarski (1999) 0.75
[Clinical significance of F2-alpha hyperprostaglandinemia in the diagnosis of bronchial asthma]. Pneumonol Pol (1982) 0.75
[Application of CO2 laser surgery in the treatment of rhinophyma]. Otolaryngol Pol (1997) 0.75
[Kinetics of plasma cyclic AMP level in atopic and non-atopic bronchial asthma after administration of triamcinolone acetonide]. Pneumonol Pol (1982) 0.75
[Proteolytic enzymes and their natural inhibitors in patients with bronchiectasis]. Wiad Lek (1987) 0.75
[Atopic rhinitis]. Otolaryngol Pol (1987) 0.75
[Evaluation of the behavior of intravascular granulocyte pools in bronchial asthma patients treated with Kenalog]. Pneumonol Pol (1981) 0.75
[Role of arachidonic acid (ETE) and its metabolites in the pathogenesis of bronchial spasm. II. Metabolites formed under the effect of lipoxygenase]. Pneumonol Pol (1983) 0.75
[Effect of histamine on behavior of the rosette test in patients with pollinosis]. Pneumonol Alergol Pol (1994) 0.75
[Lymphocyte transformation test and blood histamine level in bronchial asthma in exacerbations and remissions]. Wiad Lek (1973) 0.75
[Protracted steroid therapy in asthma. II. Immunoglobulins in endogenic asthma]. Pneumonol Pol (1980) 0.75
[Evaluation of various immunobiochemical indicators in the serum and bronchoalveolar washings of patients with bronchiectasis and atopic asthma]. Pneumonol Pol (1984) 0.75
[Assessment of perfusion disorders in asthma by means of lung scintiscanning]. Pol Tyg Lek (1976) 0.75
[Alpha-fetoprotein--diagnostic utility in squamous cell carcinoma of the head and neck]. Pol Merkur Lekarski (2001) 0.75